Latanoprost Acid

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid|(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid; 13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2?; PhXA 85; USP Latanoprost Related Compound E;|(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpent)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpenteptenoic Acid|(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoic acid|13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2α|13,14-Dihydro-17-phenyl-18,19,20-trinor-PGF2α|Latanoprost Acid|Latanoprost free acid|Latanoprost free acid (20mg in 2mL methyl acetate)|Latanoprost Related compound-E|Latanoprost USP Related Compound E|PhXA 85;|PhXA 85;Latanoprost Related Compound E;